Ji L, Lu Y, Li Q, Fu L, et al. Efficacy and safety of empagliflozin in combination with insulin in Chinese patients with type 2 diabetes and insufficient glycaemic control: A Phase III, randomised, double-blind, placebo-controlled, parallel study. Diabetes Obes Metab 2023 Mar 2. doi: 10.1111/dom.15041.
PMID: 36864540